This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Hailey D, Harstall C. Aspirin in the primary prevention of cardiovascular disease and colon cancer. Alberta Heritage Foundation for Medical Research (AHFMR) 1997: 25
To assess the evidence of effectiveness and safety in the prophylactic use of acetylsalicylic acid in the primary prevention of myocardial infarction, stroke and colon cancer.
There is insufficient evidence to support the prophylactic use of ASA in the general population to reduce the risk of myocardial infarction, stroke and colon cancer. ASA prophylaxis is effective in various groups who are at high risk for cardiovascular disease. However, more effective treatments are available for some conditions, such as atrial fibrillation, which are associated with a high risk of stroke, though such treatments are associated with a higher risk of complications.
Subject indexing assigned by CRD
Aspirin /therapeutic use; Cerebrovascular Disorders; Colorectal Neoplasms; Myocardial Infarction
Country of organisation
An English language summary is available.
Address for correspondence
1200, 10405 Jasper Avenue, Edmonton, Alberta, Canada, T5J 3N4. Tel: +1 780 448 4881; Fax: +1 780 448 0018 Email: firstname.lastname@example.org
Date bibliographic record published
Date abstract record published